The recent disruptions in global supply have highlighted the necessity of securing vital medications like Ivermectin. Dependence on overseas vendors exposes countries to potential vulnerabilities, including shipping delays, price fluctuations, and even geopolitical threats. Moving towards domestic production of Ivermectin offers a multitude of adva